Home600664 • SHA
add
Harbin Pharmaceutical Group Co Ltd
Nakaraang pagsara
¥3.88
Sakop ng araw
¥3.70 - ¥3.83
Sakop ng taon
¥3.20 - ¥4.88
Market cap
9.77B CNY
Average na Volume
144.11M
P/E ratio
30.08
Dividend yield
-
Primary exchange
SHA
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Mar 2026info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.18B | 0.02% |
Gastos sa pagpapatakbo | 770.11M | -8.79% |
Net na kita | 161.13M | -24.33% |
Net profit margin | 3.86 | -24.31% |
Kita sa bawat share | — | — |
EBITDA | 293.71M | -8.94% |
Aktuwal na % ng binabayarang buwis | 21.97% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Mar 2026info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.18B | 13.55% |
Kabuuang asset | 14.65B | 3.96% |
Kabuuang sagutin | 8.02B | 2.96% |
Kabuuang equity | 6.64B | — |
Natitirang share | 2.69B | — |
Presyo para makapag-book | 1.78 | — |
Return on assets | 4.08% | — |
Return on capital | 7.60% | — |
Cash Flow
Net change in cash
| (CNY) | Mar 2026info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 161.13M | -24.33% |
Cash mula sa mga operasyon | -186.06M | 59.95% |
Cash mula sa pag-invest | -21.14M | -20.37% |
Cash mula sa financing | -24.55M | 90.95% |
Net change in cash | -233.46M | 69.02% |
Malayang cash flow | -304.10M | 43.52% |
Tungkol
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai, a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products. Wikipedia
Itinatag
1988
Website
Mga Empleyado
10,039
